Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Dundee
Age
16–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female asthmatics aged \>/= 16 years
Females must be non pregnant and non lactating
FEV1 \>/= 50% predicted
Mannitol PD10 \</= 635 mg at end of step down period
No recent exacerbations of asthma requiring oral prednisolone in the previous 3 months
Able to perform all the techniques necessary to carry out the challenge testing and lung function and compliant with taking the study medication
Good inhaler technique which will be reinforced at each study visit
You may not be if
Male or female patients aged 15 or below
FEV1 \</= 50% predicted
Patients who are currently taking a pulse of oral corticosteroids
Patients with the following concomitant illnesses:bronchiectasis, allergic bronchopulmonary aspergillosis, COPD, heart failure, pulmonary fibrosis, rhino-sinusitis with polyps
Immunocompromised patients
Patients with recurrent LRTI
Patients with documented aspirin induced asthma on LRTAs
Pregnancy
Known or suspected hypersensitivity to ICS or other excipients of the MDIs
HIV/Hepatitis B or C positive
Clareo Health | Steroid Titration Against Mannitol IN Asthma
